Professor of Physics and Applied Physics, Harvard University
David Weitz received his PhD in physics from Harvard University and then joined Exxon Research and Engineering Company, where he worked for nearly 18 years. He then became a professor of physics at the University of Pennsylvania and moved to Harvard at the end of the last millennium as professor of physics and applied physics. He leads a group studying soft matter science with a focus on microfluidics, biophysics, materials science and flow in porous media. Several startup companies have come from his lab to commercialize research concepts.
Professor of Bioengineering, University of California
Amy Herr is a Professor of Bioengineering at the University of California, Berkeley and a Chan Zuckerberg Biohub Investigator. Prior to joining UC Berkeley, she was a staff member at Sandia National Labs, earned Ph.D. and M.S. degrees in Mechanical Engineering from Stanford University, and completed her B.S. in Engineering and Applied Science with honors from Caltech. Her research has been recognized by the NIH New Innovator Award, NSF CAREER Award, Alfred P. Sloan Fellowship (Chemistry), and DARPA Young Faculty Award, & Visionary Award from the City of Berkeley and named to the Analytical Scientist’s top 100 most influential people in analytical science.
Professor Herr has chaired the Gordon Research Conference (GRC) on the Physics & Chemistry of Microfluidics and will chair microTAS 2020. She is an elected Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and the US National Academy of Inventors, an entrepreneur, and was recently appointed to the National Advisory Council of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH. Her research program lies at the intersection of engineering design, analytical chemistry, and targeted proteomics – with a recent focus on cytometry spanning fundamental biological to clinical questions.
Professor of Cellular Neuroscience, Lund University
Malin Parmar is a professor in cellular neuroscience at Lund University in Sweden and a New York Stem Cell Foundation – Robertson investigator. Together with her lab she has shown in a series of high-profile publications how human fibroblasts can be converted into neurons, how glial cells can be reprogrammed into neurons in vivo, and how functional dopamine neurons can be generated from human embryonic stem cells.
She is the recipient of an ERC starting grant and an ERC Consolidator grant. Her research has a strong translational focus, she leads the European effort STEM-PD, designed to bring stem cell-derived dopamine neurons to clinical trials, and she collaborates within European and International networks as well as Industry partners to develop new, cell based therapies for Brain Repair with focus on Parkinson’s Disease.
The 19th Human Proteome Organization World Congress will bring together biopharma and biotech drug developments with a theme of ‘Clinical Proteomics for the Benefit of Patients’ for the first time involving Pharma industry in one of the foremost arena for the advancements of life sciences.
Keep up to date with Official Congress News Sign Up
CONGRESS SECRETARIAT International Conference Services LTD (ICS)
#300-1201 West Pender Street
Vancouver, BC, Canada V6E 2V2